drugset

drugset / Trial / NCT03090724

Pharmacokinetics of BIA 5-453 and Its Metabolites

NCT03090724 ↗

Phase 1 Completed 25 enrolled Bial - Portela C S.A.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to assess the effects of age on the pharmacokinetic (PK) profile of BIA 5-453 and its metabolites.

Timeline

Start: 2008-06-13
Primary completion: 2008-08-12
Completion: 2008-08-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BIA 5-453	Unknown	100 mg	Oral

Indications